A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes | British Journal of Ophthalmology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via AAO

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Clinical science

A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes

Free

Online download statistics by month:

Online download statistics by month: August 2019 to February 2023

	Abstract	Full	Pdf
Aug 2019	2144	45	16
Sep 2019	788	21	5
Oct 2019	226	6	1
Nov 2019	108	12	4
Dec 2019	83	11	6
Jan 2020	136	17	3
Feb 2020	145	18	7
Mar 2020	372	271	29
Apr 2020	337	333	57
May 2020	119	115	30
Jun 2020	82	77	22
Jul 2020	85	81	17
Aug 2020	73	69	23
Sep 2020	76	73	19
Oct 2020	94	91	21
Nov 2020	61	59	17
Dec 2020	89	76	16
Jan 2021	76	71	14
Feb 2021	65	60	24
Mar 2021	65	63	23
Apr 2021	67	64	13
May 2021	47	44	12
Jun 2021	46	47	26
Jul 2021	57	57	22
Aug 2021	91	89	23
Sep 2021	49	47	20
Oct 2021	83	76	18
Nov 2021	90	83	27
Dec 2021	103	105	14
Jan 2022	105	100	18
Feb 2022	67	64	17
Mar 2022	82	80	13
Apr 2022	61	62	16
May 2022	79	79	20
Jun 2022	72	70	7
Jul 2022	53	56	9
Aug 2022	86	83	10
Sep 2022	59	59	16
Oct 2022	71	70	17
Nov 2022	59	56	17
Dec 2022	48	45	12
Jan 2023	40	42	10
Feb 2023	53	53	11
Total	6792	3100	722